Report Overview
Welcome to ISR’s Biologic API CDMO Benchmarking for New & Emerging Biopharma report. Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma landscape within the biologics space. This analysis will help new and emerging biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.
ISR understands the need for a deeper dive regarding the new and emerging biopharma landscape. This report provides pharmaceutical companies and contract manufacturers comprehensive analysis of current outsourcing trends and practices, CMO selection drivers, and CMO perceptions and interactions specific to the new and emerging audience. Findings are based on 119 service encounters from 45 respondents who have been involved in outsourced large molecule API projects in the past 18 months.
What you will learn:
New and Emerging Drug Developers
- Uncover which CMO attributes drive outsourcing partner selection for outsourced large molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
- Gain insight into CMO customer loyalty, based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience
- Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs
Contract Manufacturers
- Understanding your company’s competitive positioning and market awareness, and use this information to develop targeted messaging to new and emerging biopharma companies
- Gain insight into drug developers’ outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced large molecule API manufacturing
Major Topics:
- Outsourcing Philosophies and Practices
- CMO Selection Drivers
- CMO Perceptions and Interactions
- Study Data
- Demographics
